Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check6 days agoChange DetectedNo meaningful changes detected between the two screenshots of the Study Details page for NCT01585194.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference4%

- Check42 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0 with substantial addition of immunology-related terms and related categories.SummaryDifference1%

- Check56 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element has been removed. Core content remains unchanged.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has added significant medical content related to uveal melanoma and various types of antibodies, while removing several related topics and location details.SummaryDifference4%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.